Kirsti Iiona Elder, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
- Since medical school
- 41 years
- Tulane University School of Medicine, 1985
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Elder’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A42867 · Current
Licensed to practise in California · since 1986 · expires 2027-12-31 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$2,896
Medicare paid this office $2,896 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 11 | $655 | $60 |
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 76 · Women 58% · Also on Medicaid 39% · Health risk score 1.34. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 73% · Coronary heart disease 42%.
The office billed $8,978, Medicare allowed $3,633 and paid $2,896; for 33 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 33 | 76 | 1.34 | $8,978 | $2,896 |
| 2023 | 162 | 212 | 74 | 1.28 | $61,151 | $13,296 |
| 2022 | 106 | 240 | 71 | 1.29 | $86,711 | $17,433 |
| 2021 | 103 | 175 | 72 | 1.74 | $77,823 | $12,769 |
| 2020 | 63 | 77 | 71 | 1.68 | $19,955 | $4,752 |
| 2018 | 109 | 114 | 76 | 1.43 | $22,200 | $6,283 |
| 2017 | 196 | 232 | 74 | 1.33 | $43,906 | $13,135 |
| 2016 | 190 | 292 | 74 | 1.47 | $63,402 | $18,342 |
| 2015 | 237 | 289 | 72 | 1.50 | $47,801 | $14,087 |
| 2014 | 209 | 253 | 74 | 1.28 | $45,802 | $13,507 |
| 2013 | 84 | 96 | 69 | 1.25 | $14,278 | $4,222 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 43 | $3,672 | $64 |
| Short return visit (20+ min) | 55 | $3,177 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $2,001 | $71 |
| Return visit (30+ min) | 21 | $1,821 | $87 |
| Short return visit (20+ min) | 25 | $1,179 | $44 |
2022: 4 services
| Return visit (30+ min) | 57 | $7,072 | $69 |
| Short return visit (20+ min) | 43 | $2,835 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $2,561 | $102 |
| New patient visit (30+ min) | 16 | $1,087 | $68 |
2021: 4 services
| Return visit (30+ min) | 43 | $4,916 | $76 |
| Short return visit (20+ min) | 27 | $1,737 | $54 |
| New patient visit (30+ min) | 16 | $1,199 | $75 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $671 | $56 |
2020: 3 services
| Return visit (30+ min) | 16 | $1,253 | $70 |
| Short return visit (20+ min) | 22 | $1,099 | $46 |
| Short return visit (20+ min) | 13 | $635 | $49 |
2018: 2 services
| Return visit (30+ min) | 55 | $3,428 | $62 |
| Short return visit (20+ min) | 28 | $1,132 | $40 |
2017: 3 services
| Return visit (30+ min) | 116 | $7,436 | $61 |
| Short return visit (20+ min) | 54 | $2,393 | $44 |
| New patient visit (30+ min) | 19 | $838 | $44 |
2016: 8 services
| Return visit (30+ min) | 62 | $4,417 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,958 | $64 |
| Short return visit (20+ min) | 62 | $2,431 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,701 | $121 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,446 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,111 | $93 |
| New patient visit (15+ min) | 16 | $641 | $40 |
| New patient visit (30+ min) | 11 | $575 | $52 |
2015: 5 services
| Short return visit (20+ min) | 149 | $6,064 | $39 |
| Return visit (30+ min) | 42 | $2,610 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,558 | $65 |
| New patient visit (30+ min) | 14 | $752 | $54 |
| New patient visit (15+ min) | 17 | $539 | $32 |
2014: 3 services
| Short return visit (20+ min) | 100 | $4,087 | $39 |
| Return visit (30+ min) | 60 | $3,837 | $62 |
| New patient visit (15+ min) | 21 | $715 | $34 |
2013: 2 services
| Short return visit (20+ min) | 54 | $2,394 | $41 |
| New patient visit (15+ min) | 13 | $540 | $42 |
Medicaid work
$5,259 in 2022
Medicaid paid $5,259 for 141 billed services this clinician did in 2022, up to 44 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 44 | $1,760 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose | 37 | $1,480 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose | 25 | $980 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose | 23 | $920 |
| Return visit (30+ min) | 12 | $119 |
| 2022 | 141 | 5 | 44 | $5,259 |
| 2021 | 3,061 | 6 | 645 | $115,685 |
| 2020 | 2,884 | 23 | 335 | $103,548 |
| 2019 | 8,210 | 28 | 294 | $351,228 |
| 2018 | 125 | 5 | 35 | $7,774 |
See the largest Medicaid services in earlier years
2021
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 1,247 | $44,686 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 1,118 | $44,252 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 216 | $8,547 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose | 188 | $7,510 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 186 | $6,521 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 106 | $4,170 |
2020
| Clinic visit/encounter, all-inclusive | 627 | $96,571 |
| Short return visit (20+ min) | 919 | $3,987 |
| New patient visit (30+ min) | 63 | $696 |
| Return visit (30+ min) | 140 | $481 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 119 | $436 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 244 | $289 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 17 | $201 |
| Short return visit | 72 | $171 |
| Screening test, pure tone, air only | 51 | $170 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 297 | $163 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 34 | $120 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 110 | $112 |
2019
| Clinic visit/encounter, all-inclusive | 2,299 | $319,402 |
| Short return visit (20+ min) | 1,819 | $15,108 |
| Return visit (30+ min) | 468 | $4,494 |
| New patient visit (30+ min) | 120 | $3,019 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 94 | $2,447 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 162 | $1,050 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 384 | $957 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 25 | $801 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 701 | $788 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 1,135 | $661 |
| Screening test, pure tone, air only | 245 | $607 |
| Short return visit | 111 | $402 |
2018
| Clinic visit/encounter, all-inclusive | 65 | $7,544 |
| Short return visit (20+ min) | 19 | $185 |
| Return visit (30+ min) | 13 | $34 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 14 | $7 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $4 |
Drugs they prescribed that Part D paid
$11,576
Pharmacies billed $11,576 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 103) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
89 generic and 14 brand-name prescriptions · $11,576 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 16 | $52 | $3 |
Year by year
| 2024 | 103 | 45 | 0% (0) | 14% | $11,576 |
| 2023 | 842 | 118 | 2% (20) | None | $104,798 |
| 2022 | 895 | 143 | 4% (31) | None | $80,400 |
| 2021 | 385 | 127 | 8% (29) | None | $25,839 |
| 2020 | 175 | 44 | None | None | $9,236 |
| 2019 | 214 | 51 | None | None | $23,461 |
| 2018 | 76 | 56 | None | 25% | $4,049 |
| 2017 | 146 | 91 | None | 25% | $9,494 |
| 2016 | 157 | 85 | None | 26% | $8,631 |
| 2015 | 152 | 107 | 9% (14) | 20% | $4,279 |
| 2014 | 161 | 97 | 7% (11) | 21% | $6,076 |
| 2013 | 381 | 96 | None | 16% | $15,142 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Jardiance | 15 | $25,570 | $1,705 |
| Tradjenta | 11 | $6,241 | $567 |
| Atorvastatin | 73 | $1,061 | $15 |
| Levothyroxine | 41 | $673 | $16 |
| Gabapentin | 28 | $670 | $24 |
| Metformin Hcl Er | 19 | $638 | $34 |
| Rosuvastatin | 30 | $549 | $18 |
| Amlodipine Besylate | 35 | $516 | $15 |
| Losartan | 23 | $497 | $22 |
| Fluticasone Propionate | 18 | $469 | $26 |
| Metoprolol | 23 | $380 | $17 |
| Pantoprazole | 14 | $375 | $27 |
| Metformin | 22 | $217 | $10 |
| Alendronate | 21 | $209 | $10 |
| Trazodone | 15 | $177 | $12 |
| Simvastatin | 19 | $160 | $8 |
| Donepezil | 11 | $143 | $13 |
| Hydrochlorothiazide | 12 | $139 | $12 |
| Omeprazole | 18 | $119 | $7 |
| Sertraline | 12 | $115 | $10 |
| Lisinopril | 13 | $90 | $7 |
| Sildenafil Citrate | 12 | $33 | $3 |
2022: 25 drugs
| Jardiance | 12 | $17,562 | $1,464 |
| Levothyroxine | 46 | $798 | $17 |
| Rosuvastatin | 29 | $749 | $26 |
| Gabapentin | 17 | $748 | $44 |
| Atorvastatin | 74 | $694 | $9 |
| Pantoprazole | 27 | $600 | $22 |
| Losartan | 37 | $571 | $15 |
| Hydroxyzine | 12 | $415 | $35 |
| Metoprolol | 20 | $361 | $18 |
| Duloxetine | 12 | $317 | $26 |
| Fluticasone Propionate | 14 | $305 | $22 |
| Metformin | 23 | $282 | $12 |
| Amlodipine Besylate | 28 | $261 | $9 |
| Hydrocodone-Acetaminophen | 14 | $260 | $19 |
| Hydralazine | 13 | $232 | $18 |
| Metformin Hcl Er | 12 | $227 | $19 |
| Simvastatin | 17 | $194 | $11 |
| Donepezil | 13 | $172 | $13 |
| Propranolol | 12 | $171 | $14 |
| Lactulose | 12 | $167 | $14 |
| Alendronate | 17 | $118 | $7 |
| Trazodone | 16 | $116 | $7 |
| Hydrochlorothiazide | 15 | $76 | $5 |
| Clopidogrel | 11 | $52 | $5 |
| Lisinopril | 12 | $40 | $3 |
2021: 8 drugs
| Buprenorphine | 15 | $4,844 | $323 |
| Pantoprazole | 11 | $248 | $23 |
| Metoprolol | 11 | $241 | $22 |
| Atorvastatin | 17 | $222 | $13 |
| Losartan | 13 | $206 | $16 |
| Omeprazole | 12 | $105 | $9 |
| Amlodipine Besylate | 11 | $64 | $6 |
| Metformin | 11 | $61 | $6 |
2020: 2 drugs
| Lisinopril | 12 | $81 | $7 |
| Metformin | 15 | $70 | $5 |
2019: 4 drugs
| Elmiron | 11 | $11,811 | $1,074 |
| Atorvastatin | 18 | $202 | $11 |
| Levothyroxine | 11 | $189 | $17 |
| Metformin | 19 | $150 | $8 |
2017: 1 drug
| Azithromycin | 13 | $81 | $6 |
2015: 2 drugs
| Azithromycin | 12 | $71 | $6 |
| Cephalexin | 11 | $50 | $5 |
2013: 11 drugs
| Metformin | 26 | $511 | $20 |
| Pravastatin | 16 | $386 | $24 |
| Fluticasone Propionate | 14 | $327 | $23 |
| Fosinopril | 12 | $306 | $26 |
| Omeprazole | 13 | $302 | $23 |
| Simvastatin | 20 | $291 | $15 |
| Amlodipine Besylate | 24 | $255 | $11 |
| Levothyroxine | 17 | $241 | $14 |
| Hydrochlorothiazide | 20 | $215 | $11 |
| Ibuprofen | 13 | $111 | $9 |
| Atenolol | 12 | $94 | $8 |
Professional record
- NPI
- 1689769309
- Licence
- CA A42867California A42867: Current · expires 2027-12-31
- Trained
- Tulane University School of Medicine, 1985 · 41 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A428670
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RG0300X (207RG0300X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-10-04
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.